结论：脑出血后3年以内再发危险性较大，积极控制高血压有助于防止脑出血再发。
Conclusion: the risk of recurrence of ICH is relatively high within the first 3 years after the previous hemorrhage. Hypertension control may help the prevention of recurrent ICH.
结论脑出血后3年以内复发危险性较大，积极控制高血压有助于防止脑出血复发。
Conclusion the risk of recurrence of ICH is relatively high within the first 3 years after the previous hemorrhage. Hypertension control may help the prevention of recurrent ICH.
结论：微创引流术治疗高血压脑出血效果明显优于保守治疗，是治疗高血压脑出血切实可行的方法。
Conclusion: Minimally invasive surgery is a, safe and effective method in the treatment of hypertensive intracerebral hemorrhage.
方法回顾性分析过去3年156例高血压脑出血的护理资料及高血压脑出血的死亡原因。
Methods The clinical data of nursing and causes for death in 156 cases of hypertensive cerebral hemorrhage in past 3 years were reviewed and analyzed.
方法在双肾双夹法复制肾血管性高血压模型的基础上，以胶原酶加肝素脑内注射诱发脑出血，建立高血压性脑出血大鼠模型。
Methods On the base of renovascular hypertensive rats (RHR) model, the hypertensive cerebral hemorrhage rat model was induced by injecting collagenase and heparin into the brain.
结论：脑出血后头痛与血压升高是高血压性脑出血的早期症状，但不能作为确诊依据，仅供临床参考。
Conclusion:It is eary symptom of hypertensive cerebral hemorrhage tha cerebral hemorrhage headache ad blood pressure rising But it doesn' t identify the disease only for clinical reference.
结论：高血压病为脑出血的常见病因，CAA是脑出血的重要病因，并具有重要的临床意义。
Conclusion: The causes of cerebral hemorrhage include hypertension and cerebral amyloid angiopathy, and CAA may have an important clinical value.
目的探讨无框架立体定向机器人辅助手术系统在高血压脑出血治疗中的应用价值及高血压脑出血超早期治疗的疗效。
Objective To evaluate the application value and the therapeutic effect of frameless stereotactic robotic system in the treatment of hypertensive cerebral hemorrhage.
目的探讨无框架立体定向机器人辅助手术系统在高血压脑出血治疗中的应用价值及高血压脑出血超早期治疗的疗效。
Objective To evaluate the application value and the therapeutic effect of frameless stereotactic robotic system in the treatment of hypertensive cerebral hemorrhage.
应用推荐